Sam Beckman Fried, founder of the Psychedelic Science Funders Collaborative, used a stimulant patch called EMS AM, typically used to treat depression or Parkinson's, as an off-label drug for its alertness and focus benefits while he was around 19 years old. A 2019 post on a website for users of this drug highlighting his use of it gained attention on social media.